The report analyzes development strategies for 347 colorectal cancer drugs in different stages of development. The analysis looks at drug targets and drug target strategies.
Related Articles on Drug Development:
MIT Researcher: Device and Drug Combos Carry Greater Risk, Reward
USC School of Pharmacy Establishes International Center for Regulatory Science
FDA Reports Increase in New Drug Approvals in FY 2011
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
